Shandong Zezheng Pharmaceutical Technology Co., Ltd.

The main purpose of the study is to use the eltrombopag ethanolamine dry suspension (trade name: Promacta Kit) licensed by Novartis Pharmaceuticals Corporation as the reference preparation and the eltrombopag ethanolamine dry suspension developed by Shandong Zezheng Pharmaceutical Technology Co., Ltd. as the test preparation to evaluate the human bioequivalence of the two preparations through a single-center, open, randomized, single-dose, two-sequence, two-cycle double-crossover clinical study. Secondary purpose of the study: Preliminary evaluation of the safety of the test preparation and the reference preparation in healthy subjects.